Compounds > fludarabine

fludarabine and Tumor Lysis Syndrome

fludarabine has been researched along with Tumor Lysis Syndrome in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (36.84)18.2507
2000's9 (47.37)29.6817
2010's3 (15.79)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brierley, CK; Eyre, TA1
Kawakami, T; Kitano, K; Mimura, Y; Nakazawa, H; Nakazawa, K; Nishina, S; Sakai, K; Senoo, Y1
Blum, KA; Brooker-McEldowney, M; Byrd, JC; Dalton, JT; Farley, KL; Fischer, B; Grever, MR; Heerema, NA; Hurh, E; Jarjoura, D; Johnson, AJ; Lin, TS; Mitchell, SM; Moran, ME; Phelps, MA; Rozewski, DM; Schaaf, LJ; Wu, D1
Kosseifi, SG; Krishnaswamy, G; Smith, S; Vyas, B; Vyas, H1
Bloor, A; Bosch, F; Bühler, A; Chanan-Khan, AA; Coutré, S; Dreisbach, L; Ferrajoli, A; Frankfurt, O; Furman, RR; Gobbi, M; Gribben, JG; Hallek, M; Heerema, NA; Hillmen, P; Hurd, DD; Kimby, E; Mahadevan, D; Moutouh-de Parseval, L; Sekeres, MA; Shah, S; Stilgenbauer, S; Uharek, L; Wendtner, CM; Zhang, J1
Basok, A; Mostoslavsky, M; Rogachev, B; Shnaider, A; Tovbin, D1
Clouse, LH; Hussain, K; Mazza, JJ1
Majumdar, G; Ramachandran, A1
Adam, K; Bergmann, J; Buchheidt, D; Hehlmann, R; Hummel, M; Reiter, S1
Audouin, J; Compérat, E; Delmer, A; Diebold, J; Le Tourneau, A; Molina, TJ1
Coiffier, B; Rioufol, C1
Calvo-Villas, JM; Sicilia, F; Umpierrez, AM; Urcuyo, BM1
Aguilera, A; Liaño, F; Montalban, C1
Dean, MG; Mulligan, SP1
Cannon, LM; Garfinkel, H; Pezzimenti, J; Rhodes, R; Spilove, L1
Behrens, J; Killick, S; Mercieca, J; Nandi, A1
Cheson, BD; Frame, JN; Quashu, N; Sorensen, JM; Vena, D1
Leach, M; Parsons, RM; Reilly, JT; Winfield, DA1
Crowley, S; Dahut, WL; Frame, JN1

Reviews

2 review(s) available for fludarabine and Tumor Lysis Syndrome

ArticleYear
Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
    Tennessee medicine : journal of the Tennessee Medical Association, 2009, Volume: 102, Issue:10

    Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Risk Factors; Tumor Lysis Syndrome; Vidarabine

2009
Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    American journal of hematology, 2003, Volume: 72, Issue:3

    Topics: Aged; Antineoplastic Agents; Blood Urea Nitrogen; Calcium; Creatinine; Fatal Outcome; Fluid Therapy; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Phosphorus; Potassium; Renal Dialysis; Tumor Lysis Syndrome; Uric Acid; Vidarabine

2003

Trials

2 trial(s) available for fludarabine and Tumor Lysis Syndrome

ArticleYear
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia.
    Blood, 2009, Mar-19, Volume: 113, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Cell Cycle; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Inactivation, Metabolic; Infusions, Intravenous; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Models, Biological; Piperidines; Protein Kinase Inhibitors; Recurrence; Salvage Therapy; Treatment Outcome; Tumor Lysis Syndrome; Uridine Diphosphate Glucuronic Acid; Vidarabine

2009
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Allopurinol; Antimetabolites, Antineoplastic; Dose-Response Relationship, Immunologic; Drug Resistance, Neoplasm; Female; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Recurrence; Salvage Therapy; Thalidomide; Thrombocytopenia; Tumor Lysis Syndrome; Vidarabine

2012

Other Studies

15 other study(ies) available for fludarabine and Tumor Lysis Syndrome

ArticleYear
Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.
    Blood, 2017, 06-22, Volume: 129, Issue:25

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Ear, External; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hearing Loss, Unilateral; Humans; Idarubicin; Leukemia, Monocytic, Acute; Leukemic Infiltration; Male; Orbit; Tumor Lysis Syndrome; Vidarabine

2017
Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy.
    International journal of hematology, 2014, Volume: 99, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Female; Humans; Immunohistochemistry; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Pleural Effusion; Treatment Outcome; Tumor Lysis Syndrome; Vidarabine

2014
Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome.
    The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:9

    Topics: Acute Kidney Injury; Antineoplastic Agents; Female; Humans; Hypoglycemia; Leukemia, Lymphoid; Middle Aged; Severity of Illness Index; Tumor Lysis Syndrome; Vidarabine

2002
Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:6

    Topics: Acute Kidney Injury; Administration, Oral; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Lysis Syndrome; Vidarabine

2004
Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
    European journal of haematology, 2005, Volume: 75, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Creatinine; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Recombinant Proteins; Renal Insufficiency; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine

2005
Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia.
    Archives of pathology & laboratory medicine, 2006, Volume: 130, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epstein-Barr Virus Infections; Fatal Outcome; Herpesvirus 4, Human; Humans; Immunoglobulin A; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Tumor Lysis Syndrome; Vidarabine

2006
Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
    Onkologie, 2008, Volume: 31, Issue:4

    Topics: Administration, Oral; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Tumor Lysis Syndrome; Vidarabine

2008
Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
    Onkologie, 2008, Volume: 31, Issue:4

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vidarabine

2008
Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
    Postgraduate medical journal, 1994, Volume: 70, Issue:827

    Topics: Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Tumor Lysis Syndrome; Vidarabine

1994
Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:4

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Tumor Lysis Syndrome; Vidarabine

1994
Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Connecticut medicine, 1993, Volume: 57, Issue:10

    Topics: Acute Disease; Aged; Antineoplastic Agents; Fatal Outcome; Female; Humans; Leukemia, Prolymphocytic; Tumor Lysis Syndrome; Vidarabine

1993
Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma.
    Clinical and laboratory haematology, 1997, Volume: 19, Issue:1

    Topics: Acute Disease; Aged; Humans; Lymphoma, Non-Hodgkin; Male; Renal Dialysis; Tumor Lysis Syndrome; Vidarabine

1997
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Tumor Lysis Syndrome; Vidarabine

1998
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
    Clinical and laboratory haematology, 1998, Volume: 20, Issue:3

    Topics: Aged; Allantoin; Antimetabolites, Antineoplastic; Diuresis; Drug Evaluation; Female; Humans; Kidney Calculi; Kidney Diseases; Kidney Tubules; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oliguria; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine

1998
Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
    The New England journal of medicine, 1992, Nov-05, Volume: 327, Issue:19

    Topics: Acute Kidney Injury; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Tumor Lysis Syndrome; Vidarabine

1992